MedPath

Non-invasive Hemoglobin Monitoring in Outpatient Total Joint Arthroplasty

Completed
Conditions
Total Joint Arthroplasty
Registration Number
NCT05369325
Lead Sponsor
Mayo Clinic
Brief Summary

This research is being done to better understand the accuracy of noninvasive hemoglobin tests on patients that recently underwent total joint arthroplasty.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
200
Inclusion Criteria
  • Adult patients age ≥ 18.
  • Undergoing either primary total knee or total hip arthroplasty for a primary underlying diagnosis of osteoarthritis.
Read More
Exclusion Criteria
  • Individuals < 18 years of age.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Concordance between non-invasive Hgb and serum Hgb1 hour

How closely the non-invasive and serum Hgbs correlate with one another statistically

Patient satisfaction with non-invasive Hgb1 day

Patients will get a survey to fill out following the Hgb measurements that assesses their satisfaction with the non-invasive method

Nurse satisfaction with non-invasive Hgb1 day

Nurses will get a survey to fill out following the Hgb measurements that assesses their satisfaction with the non-invasive method

Cost comparison between non-invasive and serum Hgb1 year

We will analyze cost differences between the non-invasive Hgb devices and the serum lab tests

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Mayo Clinic Rochester

🇺🇸

Rochester, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath